2070015-02-8
2070015-02-8
Chemical Structure
CBB1003 hydrochloride
- CAS No.: 2070015-02-8
- Formula:C25H36Cl5N9O4
- Molecular Weight:703.88
IUPAC Name: 4-(3-(4-(4-carbamimidoylbenzoyl)piperazine-1-carbonyl)-5-nitrobenzyl)piperazine-1-carboximidamide pentahydrochloride
InChIKey: NPEZOGXTPWOUBZ-UHFFFAOYSA-N
SMILES: NC(N1CCN(CC2=CC(C(N3CCN(C(C4=CC=C(C(N)=N)C=C4)=O)CC3)=O)=CC([N+]([O-])=O)=C2)CC1)=N.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl
Biological Activity:
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CBB1003 hydrochloride | CBB1003 Hcl is a novel histone demethylase LSD1 inhibitor with IC50 of 10. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- Wang J, et al. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. Cancer Res. 2011 Dec 1;71(23):7238-49. [Content Brief]
- Hsu HC, et al. CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression. J Cancer Res Clin Oncol. 2014 Jul 25. [Content Brief]
Keywords
